Hunger in America

Patients taking opioid dosages at or above 50 MME/day are twice as likely to overdose compared to those taking 20 MME/day, and the risk further increases as the MME/day increases.

In 2011, the opioid crisis reached astounding levels with over 21,000 deaths adding to the urgency of providing aid to those who most need it

Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections

The COVID-19 pandemic forced discussions about social determinants of health (SDOH) back into the forefront of healthcare discussions. Knowing that 80% of a person’s health outcomes are impacted by these external factors – economic, social, community, education, and more – we, as industry leaders, must shift these discussions about SDOH implementation from a lofty goal into a reality. How do we get there?

Patients taking opioid dosages at or above 50 MME/day are twice as likely to overdose compared to those taking 20 MME/day, and the risk further increases as the MME/day increases.